Merck Keytruda Rivalry Surges as Ivonescimab Stumbles
Is the latest ivonescimab setback a temporary stumble or a turning point in the Merck Keytruda Rivalry for lung cancer dominance?
Amgen Earnings -5.3% Plunge: Guidance Shock Despite Upgrade
Are the latest Amgen Earnings a buying opportunity after the stock’s sudden plunge, or a warning sign that growth is stalling?
Seagate Earnings +6.2% Surge as AI Storage Boom Accelerates
Are Seagate Earnings signaling a one-off AI hype spike or the start of a structurally higher era for data-center storage?
Oracle AI Infrastructure Soars 7.6% in Rally Shock
Can Oracle’s multibillion‑dollar AI infrastructure bet really justify today’s sharp stock rally after weeks of bruising losses?
Salesforce AI Reporting +169% Surge Puts Agentforce in Focus
Can Salesforce’s new AI reporting overhaul and explosive Agentforce growth finally convince investors it is a true AI platform, not legacy SaaS?
Roku Earnings +22% Surge: Q1 Boom Ignites Wall Street
Can Roku’s latest earnings surge and guidance hike turn its connected TV scale into lasting profit power for shareholders?
Intel Management Shift +4.8% Rally Meets Quantum Bet
Is the Intel Management Shift toward quantum bets powering a durable AI rally or setting up investors for a sharp reversal?
Qualcomm Earnings -3.9%: AI Data Center Pivot Under Pressure
Can Qualcomm’s bold AI and data center push offset handset weakness as the stock slides 3.9% after recent earnings euphoria?
Micron Forecast $1,000: Can the AI Memory Rally Last?
Is the bold Micron Forecast for a $1,000 share price a realistic AI supercycle bet or late‑cycle euphoria?
Apple Earnings +17%: Record Rally and Guidance Shock Wall Street
Can blockbuster Apple Earnings and a surprise outlook justify the latest rally, or is investor optimism running too far ahead?